5 active not recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 5 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Rapcabtagene autoleucel: new trials by email Literature Review of Rapcabtagene autoleucel trials Research Report on Rapcabtagene autoleucel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease Rapcabtagene autoleucel - Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD) | Phase 1 / Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 27 | 2025-06-20 | 2026-09-04 |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA Rapcabtagene autoleucel, Active Comparator, Glucocorticoids - ANCA Associated Vasculitis (AAV) | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 126 | 2025-03-13 | 2026-09-04 |
| Phase 2 Study of Rapcabtagene Autoleucel in Myositis Rapcabtagene autoleucel, Active Comparator Option - Idiopathic Inflammatory Myopathies | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 21 | 2024-12-17 | 2026-06-23 |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis rapcabtagene autoleucel, rituximab - Scleroderma, Diffuse | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 96 | 2024-10-29 | 2026-09-02 |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) rapcabtagene autoleucel - Lupus Erythematosus, Systemic, Lupus Nephritis | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 179 | 2024-09-04 | 2026-09-02 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Rheumatoid (1) · Dermatomyositis (1) · Granulomatosis with Polyangiitis (1) · Lung Diseases, Interstitial (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Microscopic Polyangiitis (1) · Myositis (1) · Scleroderma, Diffuse (1) · Vasculitis (1)
Singapore (5) · Brazil (4) · France (4) · Germany (4) · Israel (4) · Japan (4) · Spain (4) · Switzerland (4) · United Kingdom (4) · United States (4) · Australia (3) · Italy (3) · Netherlands (3) · Saudi Arabia (3) · Taiwan (3)
2023 (2)